Opto Biosystems
Opto Biosystems develops healthcare tech linking cancer neuroscience with bioelectronics for new treatments.
Opto Biosystems is active in the health care, medical, medical device space based in Europe, Middle East, and Africa (EMEA), founded in 2022.
Opto Biosystems is positioned in health care, medical, medical device, a segment that rewards a clear, focused offering.
Its base of operations is Europe, Middle East, and Africa (EMEA).
It is recorded at the Pre_Seed stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $1.9M in funding.
| Sector | Health Care, Medical, Medical Device |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | pre_seed |
| Total funding | $1,850,000 |
Website: www.opto.bio
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account